Disclosures Vanderbilt Institutional Review Board approved this - - PDF document

disclosures
SMART_READER_LITE
LIVE PREVIEW

Disclosures Vanderbilt Institutional Review Board approved this - - PDF document

AN INNOVATIVE MUCOSAL IMPEDANCE DEVICE DIFFERENTIATES ACTIVE EOSINOPHILIC ESOPHAGITIS FROM INACTIVE DISEASE, NERD, AND CONTROLS Mary Allyson Lowry, MD 1 Michael Vaezi, MD, MS, PhD 2 Hernan Correa, MD 3 Chris Slaughter, DrPH 4 Tina Higginbotham, MPA


slide-1
SLIDE 1

1

AN INNOVATIVE MUCOSAL IMPEDANCE DEVICE DIFFERENTIATES ACTIVE EOSINOPHILIC ESOPHAGITIS FROM INACTIVE DISEASE, NERD, AND CONTROLS

Mary Allyson Lowry, MD1 Michael Vaezi, MD, MS, PhD2 Hernan Correa, MD3 Chris Slaughter, DrPH4 Tina Higginbotham, MPA2 Sari Acra, MD, MPH1

Division of Pediatric Gastroenterology, Hepatology and Nutrition1 Division of Gastroenterology, Hepatology and Nutrition2 Department of Pediatric Pathology3 Department of Biostatistics4 Vanderbilt University Medical Center

Disclosures

  • Vanderbilt Institutional Review Board approved

this study

  • Vanderbilt University holds the patent with

Sandhill Scientific Inc. for the device

  • The principal investigator, Mary Allyson Lowry,

received grant funding under the Vanderbilt Training Grant in Gastroenterology

– NIH grant 2T32DK007673‐21 and 5T32 DK007673‐22

  • The other authors of this study have no financial

disclosures

Background

  • Eosinophilic esophagitis (EoE), gastroesophageal reflux

disease (GERD), and non‐erosive esophageal reflux

disease (NERD) are common diseases of both adult and

pediatric patients

  • Share clinical and histological features
  • Require multiple endoscopies with biopsies or pH‐

impedance monitoring

slide-2
SLIDE 2

2 Diagnostic Protocols

Sedated endoscopy with biopsies Sedated endoscopy with biopsies +/- Multichannel intraluminal impedance

Dietary or Topical Steroid Treatment

Repeat sedated endoscopy with biopsies

Food Challenge

Repeat sedated endoscopy with biopsies

Symptomatic

Repeat sedated endoscopy with biopsies

Symptomatic

Repeat sedated endoscopy with biopsies

EoE GERD/ NERD

Acid Blockade Treatment Food Challenge

Introduction

There is a need for an accurate means of diagnosing chronic mucosal changes due to EoE, GERD, and NERD

  • Timely
  • Inexpensive
  • Reduced Risks

Cellular Level

Inflammation compromises the esophageal epithelial barrier

Normal Eosinophilia Spongiosis

slide-3
SLIDE 3

3

MI is a measurement of current across the epithelium which can distinguish normal vs inflamed mucosa Validated by adult studies

  • Focused on GERD
  • No histologic confirmation

Mucosal Impedance (MI) Device Hypothesis

We hypothesize that mucosal impedance measurement in pediatric patients will differentiate histologically‐proven active EoE from inactive EoE, GERD/NERD, and normal.

Secondary Hypothesis

We hypothesize that higher eosinophil counts and more severe degrees of spongiosis will have decreased electrical impedance compared to normal histology.

slide-4
SLIDE 4

4

Methods

  • Cross Sectional Study
  • 83 pediatric patients
  • Ages 1 year ‐18 years
  • Vanderbilt Pediatric Gastroenterology Clinic

Methods

  • MI measurements (in Ω)
  • Endoscopic placement
  • 2 cm , 5 cm and 10 cm above the squamocolumnar

junction

  • Provide instantaneous measurements
  • Routine biopsies
  • 2 cm, 5 cm and 10 cm above the squamocolumnar junction

10 cm 5 cm 2 cm

Methods

  • Pathologists blinded to MI measurements reviewed biopsies per

routine protocol

  • Spongiosis was graded on an ordinal visual scale (normal, mild,

moderate or severe).

Severe

slide-5
SLIDE 5

5

Final Diagnosis

Pediatric Patients N=83 NERD/GERD N=21 Active EoE N=16 Inactive EoE N=7 Control N=26 Other Abnormal Histology N=14

Functional Dyspepsia or IBS (56%) Functional Dyspepsia or IBS (56%) SIBO (12%) SIBO (12%) Respiratory Condition (8%) Respiratory Condition (8%) Vomiting (4%) Vomiting (4%) Celiac Disease (4%) Celiac Disease (4%) Lactase Deficiency (4%) Lactase Deficiency (4%) Helicobacter pylori (4%) Helicobacter pylori (4%) Eosinophilic Gastroenteropathy (4%) Eosinophilic Gastroenteropathy (4%)

MI by Final Diagnosis

N Active EoE Inactive EoE NERD/GERD Control P‐value 2 cm 83

655 1089 1316 1674 3242 4083 1683 2612 3249 2005 3091 4036

< 0.001 5 cm 82

973 1212 1415 2278 2682 2979 2104 2970 4863 2599 3532 4268

< 0.001 10 cm 83

1024 1572 1874 2389 2396 3382 1972 3820 4948 2895 3633 4987

0.002

a b c represent the lower quartile a, the median b, and the upper quartile c for continuous variables. N is the number of non-missing values.

Distance above the Squamocolumnar Junction

Control NERD/GERD Inactive EoE Active EoE

MI (Ohms)

MI by Final Diagnosis

slide-6
SLIDE 6

6

Eosinophil Count

MI by Eosinophil Counts

Mucosal Impedance (Ohms)

p< 0.001

MI by Spongiosis

p< 0.001

MI (Ohms) Spongiosis

Conclusions

1) MI measurements provide immediate results of esophageal mucosal inflammation in pediatric patients. 2) Active EoE patients have significantly lower MI measurements than other patients. 3) MI measurements inversely correlate with eosinophil counts and spongiosis severity. 4) This novel device has the potential to provide immediate, less invasive disease monitoring in pediatric patients with EoE, thus significantly reducing costs and risks of repeated endoscopic evaluation.

slide-7
SLIDE 7

7 Significance and Future Potential

Sedated endoscopy with biopsies Sedated endoscopy with biopsies +/- Multichannel intraluminal impedance

Dietary or Topical Steroid Treatment

Repeat sedated endoscopy with biopsies

Food Challenge

Repeat sedated endoscopy with biopsies

Symptomatic

Repeat sedated endoscopy with biopsies

Symptomatic

Repeat sedated endoscopy with biopsies

EoE GERD/ NERD

Acid Blockade Treatment

and mucosal impedance mucosal impedance mucosal impedance mucosal impedance X- Current potential X- Future potential

Food Challenge